Campaign Concepting - HCP Marketing

Ozurdex® ocular implant needed to quickly illustrate to an HCP how one procedure could significantly impact a patient’s ocular health.

Ozurdex® treats diabetic macular edema (DME) with one injection by gradually releasing medication to reduce inflammation without the need for frequent eye drops. These HCP-facing concepts demonstrate a patient’s response to a substantial improvement in visual acuity – after a physician delivers the clinically proven effectiveness of Ozurdex®.

These original concepts illustrate Matt Mighell’s consistent ability to condense complex clinical data into simple, clear, and uniquely-effective messaging that cuts through competitive clutter.